CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range
- PMID: 7490758
- DOI: 10.1006/jmbi.1995.0626
CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range
Abstract
We describe the investigation of methodologies for the creation of very high affinity human antibodies. The high affinity human antibody b4/12 was optimized for its affinity to the human envelope glycoprotein gp120 of human immunodeficiency virus type 1 (HIV-1). Five libraries of b4/12 were constructed by saturation mutagenesis of complementarity-determining regions (CDRs). Libraries of antibody Fab fragments were displayed on the surface of filamentous phage and selected in vitro for binding to immobilized gp120. Sequential and parallel optimization strategies of CDRs were examined. The sequential CDR walking strategy consistently yielded b4/12 variants of improved affinity in each of the four different optimization sequences examined. This resulted in a 96-fold improvement in affinity. Additivity effects in the antibody combining site were explored by combining independently optimized CDRs in the parallel optimization strategy. Six variants containing optimized CDRs were constructed. Improvement of affinity based on additivity effects proved to be unpredictable but did lead to a modest improvement in affinity. Indeed, only one of the six combinations demonstrated additivity. The highest affinity Fab prepared using this strategy was improved 420-fold in affinity. The affinity of this Fab was 15 pM as compared to 6.3 nM for b4/12. Examination of the kinetics of Fab binding to gp120 revealed that improvements in affinity were dominated by a slowing of the off-rate of the Fab. The methodology presented here provides a route for the improvement of the affinities of antibodies typical of tertiary immune responses into the picomolar range. Such improvements may have profound effects on the utility of antibodies as therapeutic and prophylactic agents.
Similar articles
-
Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.J Mol Biol. 1996 Feb 16;256(1):77-88. doi: 10.1006/jmbi.1996.0069. J Mol Biol. 1996. PMID: 8609615
-
Improvement in affinity and HIV-1 neutralization by somatic mutation in the heavy chain first complementarity-determining region of antibodies triggered by HIV-1 infection.Eur J Immunol. 2001 Jan;31(1):128-37. doi: 10.1002/1521-4141(200101)31:1<128::aid-immu128>3.0.co;2-t. Eur J Immunol. 2001. PMID: 11169446
-
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.Science. 2003 Jun 27;300(5628):2065-71. doi: 10.1126/science.1083182. Science. 2003. PMID: 12829775
-
Selection and evolution of high-affinity human anti-viral antibodies.Trends Biotechnol. 1996 Jul;14(7):230-4. doi: 10.1016/0167-7799(96)10029-9. Trends Biotechnol. 1996. PMID: 8771795 Review.
-
Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy.Chem Immunol. 1997;65:18-56. doi: 10.1159/000319346. Chem Immunol. 1997. PMID: 9018871 Review. No abstract available.
Cited by
-
Development of two murine antibodies against Neospora caninum using phage display technology and application on the detection of N. caninum.PLoS One. 2013;8(1):e53264. doi: 10.1371/journal.pone.0053264. Epub 2013 Jan 8. PLoS One. 2013. PMID: 23308179 Free PMC article.
-
Generating conformation-specific synthetic antibodies to trap proteins in selected functional states.Methods. 2013 Mar 15;60(1):3-14. doi: 10.1016/j.ymeth.2012.12.010. Epub 2012 Dec 29. Methods. 2013. PMID: 23280336 Free PMC article.
-
Eliminating helper phage from phage display.Nucleic Acids Res. 2006;34(21):e145. doi: 10.1093/nar/gkl772. Epub 2006 Nov 6. Nucleic Acids Res. 2006. PMID: 17088290 Free PMC article.
-
A new dawn for monoclonal antibodies against antimicrobial resistant bacteria.Front Microbiol. 2022 Dec 14;13:1080059. doi: 10.3389/fmicb.2022.1080059. eCollection 2022. Front Microbiol. 2022. PMID: 36590399 Free PMC article. Review.
-
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform.Mol Ther. 2019 Feb 6;27(2):287-299. doi: 10.1016/j.ymthe.2018.11.015. Epub 2018 Nov 20. Mol Ther. 2019. PMID: 30573301 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources